Updates in the management of chronic rhinosinusitis

Anna Slovick, Jennifer Long, Claire Hopkins*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)


    Chronic rhinosinusitis (CRS) is one of the most common chronic diseases in the UK, with an estimated prevalence of 10.4%. CRS has been shown to have a significant impact on quality of life, worse in some domains of the Short Form-36 than COPD or angina. It carries a high socioeconomic burden; with estimated healthcare costs in the USA of $772/patient/year (2011). Untreated, CRS may also cause exacerbation of co-existing asthma. Given its frequency of presentation to primary care, A&E, respiratory medicine, allergy, neurology and ENT, here, we aim to inform readers about key developments in the diagnosis and management of adult CRS, following the publication of the 2012 European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS). In particular, improved knowledge of diagnostic criteria and evidence-based care will enhance diagnostic accuracy and ensure optimal CRS management from the onset of disease; both improving symptom control and reducing secondary care referrals.

    Original languageEnglish
    Pages (from-to)649-663
    Number of pages15
    Issue number6
    Publication statusPublished - 1 Dec 2014


    • antibiotics
    • balloon sinuplasty
    • chronic
    • functionalendoscopic sinus surgery
    • intranasal corticosteroids
    • nasal polyps
    • oral steroids
    • rhinosinusitis
    • saline irrigation


    Dive into the research topics of 'Updates in the management of chronic rhinosinusitis'. Together they form a unique fingerprint.

    Cite this